Home / Inspections / 1253781

FDA Inspection 1253781 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567004

The FDA completed an inspection of Regenerative Biologics, Inc. on November 5, 2024 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 5, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)

Facility

Other inspections at this facility

  • 1098286 (NAI Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012244 (NAI Wed Mar 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914703 (NAI Thu Feb 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 829781 (NAI Wed May 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 721599 (NAI Wed Apr 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources